The use of data from the real world to address clinical and policy-relevant questions that
cannot be answered using data from clinical trials is garnering increased interest. Indeed …

Non-small-cell lung cancer (NSCLC) is a very common disease in the elderly population
and its incidence in this particular population is expected to increase further, because of the …

Purpose To evaluate the association between cumulative duration of metformin use after
prostate cancer (PC) diagnosis and all-cause and PC-specific mortality among patients with …

Background Metformin is commonly prescribed to treat type 2 diabetes. Recent evidence
suggests that it may possess antitumoral properties. The aim of this study was to test the …

Surgery is regarded as the primary treatment modality for early stage non-small cell lung
cancer (NSCLC), but even after complete resection, a substantial percentage of these …

Since the COVID‐19 outbreak started, it has been affecting mainly older individuals. Among
the most vulnerable older individuals are those with cancer. Many published guidelines and …

Lung cancer is a significant international health problem. Aligning clinical practice with
evidence‐based guideline recommendations has the potential to improve patient outcomes …

Most patients with non–small-cell lung cancer (NSCLC) are elderly, and age has important
implications for their management and treatment. In May 2014, the Italian Association of …

Lung cancer is a disease of the elderly. In older patients, the management of a malignancy
as complex and potentially as lethal as lung cancer is challenging. Despite the fact that a …

Objective To assess radical cystectomy (RC) outcomes and adjuvant chemotherapy (ACT)
use in the elderly in routine practice. Bladder cancer occurs most commonly in the elderly …